Decrease dose if: Experiencing consistent side effects (headaches, fatigue, GI disturbance), achieving satisfactory results at current dose with no need for escalation, or cost considerations favor using minimum effective dose
Therapeutic Considerations BPC-157 is more stable than its parent compound, and studies indicate that it does not require a carrier agent to elicit systemic effects
As a result, lower drug administration requirements are feasible [17], so no modification of the therapeutic agent nor coupling the drug to any carrier is required [11]
Advertisement Article continues below this ad Swelling A possible reaction to a cyanocobalamin injection is swelling
B12 levels typically normalize once the root cause is addressed
[DOI] [PubMed] [Google Scholar] 47.Tkalcevic V.I., Cuzic S., Brajsa K., Mildner B., Bokulic A., Situm K., Perovic D., Glojnaric I., Parnham M.J